Cancer in Adolescents and Young Adults: Treatment and Outcome in Victoria
Overview
Authors
Affiliations
Objectives: To describe the location of treatment, recruitment to clinical trials and outcomes for adolescents and young adults treated for cancer in Victoria.
Design And Setting: Retrospective review of all adolescents and young adults aged 10-24 years diagnosed with cancer between 1992 and 1996, identified from the Victorian Cancer Registry.
Main Outcome Measures: Treatment regimen (clinical trial, treatment protocol or neither), compliance with treatment and 5-year survival.
Results: Questionnaires were completed for 576 of 665 eligible adolescents and young adults (87% response rate). Recruitment into clinical trials decreased with increasing age. Adolescents aged 10-19 years were more likely to be recruited to a clinical trial if treated at a paediatric hospital. For all cancers, 5-year survival was similar across the age groups and was not influenced by the place of treatment. Only 1% of adolescents and young adults failed to complete planned therapy due to non-compliance.
Conclusions: Despite a similar incidence of cancer to that in younger children, adolescents and young adults with cancer are poorly recruited into clinical trials in Victoria. Establishment of a cancer resource network in Victoria may provide information to both paediatric and adult oncologists about currently available clinical trials.
Wang R, Schweitzer J, Hernandez S, Molina S, Keegan T J Clin Transl Sci. 2023; 7(1):e240.
PMID: 38028342 PMC: 10663769. DOI: 10.1017/cts.2023.669.
Ellis J, Malalasekera V, Allan C, Choong P, Hansford J, Hehir R J Adolesc Young Adult Oncol. 2021; 11(2):173-180.
PMID: 34297611 PMC: 9057899. DOI: 10.1089/jayao.2021.0026.
Lv Y, Feng Q, Wei Y, Ren L, Ye Q, Wang X Clin Transl Med. 2020; 10(3):e121.
PMID: 32627392 PMC: 7418800. DOI: 10.1002/ctm2.121.
Resource Utilization and Costs in Adolescents Treated for Cancer in Pediatric vs Adult Institutions.
Nathan P, Bremner K, Liu N, Gupta S, Greenberg M, McBride M J Natl Cancer Inst. 2018; 111(3):322-330.
PMID: 30053118 PMC: 6410950. DOI: 10.1093/jnci/djy119.
Hough R, Sandhu S, Khan M, Moran A, Feltbower R, Stiller C BMJ Open. 2017; 7(10):e017052.
PMID: 28982824 PMC: 5639992. DOI: 10.1136/bmjopen-2017-017052.